Incidence of deepening of the upper eyelid sulcus after topical use of travoprost ophthalmic solution in Japanese

Journal of Glaucoma

Volumn 23, Issue 3, 2014, Pages 160-163

  Maruyama, Katsuhiko ^a   Shirato, Shiroaki ^a,b   Tsuchisaka, Asako ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Yotsuya Shirato Eye Clinic   (Japan)

Author keywords

Side effect; Travoprost; Upper eyelid sulcus

Indexed keywords

EYE DROPS; TRAVOPROST;

ADULT; ARTICLE; CLINICAL ARTICLE; DEEPENING OF THE UPPER EYELID SULCUS; EYE DISEASE; EYE PHOTOGRAPHY; FEMALE; FOREHEAD; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; JAPANESE; MALE; MIDDLE AGED; OPEN ANGLE GLAUCOMA; OUTPATIENT; PREMEDICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYMPTOM; TREATMENT DURATION; UPPER EYELID;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CLOPROSTENOL; EYELID DISEASES; EYELIDS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES;

EID: 84893599965     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31826a7e09     Document Type: Article

References (17)

1. Hollo G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf. 2007;6: 45-52. (Pubitemid 46150523)
2. Peplinski LS, Albiani SK. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci. 2004;81: 574-577. (Pubitemid 39095648)
3. Filippopoulos T, Paula JS, Torun N, et al. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg. 2008;24: 302-307.
4. Tappeiner C, Perren B, Iliev ME, et al. Orbital fat atrophy in glaucoma patients treated with topical bimatoprost - can bimatoprost cause enophthalmos? Klin Monbl Augenheilkd. 2008;225: 443-445. (Pubitemid 352016479)
5. Yam JC, Yuen NS, Chan CW. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy. J Ocul Pharmacol Ther. 2009;25: 471-472.
6. Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues. Orbit. 2010;29: 357-359.
7. Nakakura S, Tabuchi H, Kiuchi Y. Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost. Optom Vis Sci. 2011;88: 1140-1144.
8. Suh MH, Park KH, Kim DM. Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma. Jpn J Ophthalmol. 2009;53: 18-23.
9. Yang HK, Park KH, Kim TW, et al. Deepening of eyelid superior sulcus during topical travoprost treatment. Jpn J Ophthalmol. 2009;53: 176-179.
10. Ung T, Currie ZI. Periocular changes following long-term administration of latanoprost 0.005%. Ophthal Plast Reconstr Surg. 2012;28: e24-e44.
11. Aihara M, Shirato S, Sakata R. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost. Jpn J Ophthalmol. 2011;55: 600-604.
12. Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol. 2011;55: 22-27.
13. Serrero G, Lepak NM. Prostaglandin F2 alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997;233: 200-202. (Pubitemid 27215935)
14. Liu L, Clipstone NA. Prostaglandin F2 alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurindependent signaling pathway. J Cell Biochem. 2007;100: 161-173. (Pubitemid 44958187)
15. Strong P, Coleman RA, Humphrey PP. Prostanoid-induced inhibition of lipolysis in rat isolared adipocytes: probable involvement of EP3 receptors. Prostaglandins. 1992;43: 559-566.
16. Altieri M, Ferrari E. Do prostaglandin analogs affect eyelid position and motility? J Ocul Pharmacol Ther. 2011;27: 511-517.
17. Aydin S, Işikligil I, Tekşen YA, et al. Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature. Cutan Ocul Toxicol. 2010;29: 212-216.